Mohit Manrao, President of AstraZeneca (HealthCare) Foundation, shared on LinkedIn:
“Precision medicine is generating a lot of buzz, but many people don’t realize that a personalized treatment plan often starts with a biomarker test. If you’re unfamiliar with biomarker testing, you’re not alone. Awareness remains low.
That’s why I’m excited that we just launched Meet Your Mark, AstraZeneca’s new public awareness campaign featuring Mark-Paul Gosselaar. The campaign aims to help people better understand biomarker testing and the role it can play in informing cancer treatment decisions.
Despite being recommended in treatment guidelines, only about 1 in 3 people with advanced cancer in the U.S. receive biomarker testing. We want to help change that by encouraging patients and their loved ones to ask questions and have informed conversations with their care teams.
For the oncologists and patient advocates in my network….what is the biggest barrier you see when it comes to patients understanding biomarker testing? Let’s talk about it below.
You may also be interested in: